PMC5 A STANDARD SET OF UNIT COSTS FOR GERMANY  by Schweikert, B et al.
A66 Abstracts
METHODS: Within the framework of an international project
(EUROCOST) Hospital Discharge Registers of 7 European
countries were analysed. To reduce heterogeneity, clinical inci-
dence was determined using different injury indicators, based on
a) health care use; b) anatomical criteria; or c) expected outcome.
The following existing and newly developed injury indicators
were tested: admissions excluding day cases (a), length of stay
4+ days and 7+ days (a), serious long-bone fractures (b), radio-
logical veriﬁable fractures (b), serious non-fatal injuries (c),
injuries with a moderate to high disability weight (Global Burden
of Disease weights and Dutch weights (IBIS)) (c). RESULTS:
Clinical injury incidence varied substantially in the rough data,
ranging from 6.6 to 22.9 per 1000 person years. Exclusion of
day cases and short-term admissions both led to an increased
variation in clinical incidence. The anatomical indicators
“serious long bone fractures” and “selected radiologically veri-
ﬁable fractures”, as well as both indicators based on disability
resulted in at least comparable variation in clinical incidence and
reduced variation in median length of stay in hospital as opposed
to the rough data. Contrary to rough data, those four indicators
showed reasonable (serious long bone fractures) to good associ-
ations with mortality rates. They were responsible for almost
equal parts of the hospital costs of injury (40–44%). CON-
CLUSIONS: Comparing only serious injuries with an objective
need for hospital admission based on disability weights (GBD
and IBIS) or on anatomical criteria (serious long bone fractures
and selected radiologically veriﬁable fractures) consistently
reduced the inﬂuence of registration and health care practices on
clinical incidence variation, which improved the comparability
of clinical injury incidence data.
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OBJECTIVES: To assess the contribution of prevention and
medical care to the improvement in population health, as part
of an overall assessment of the current cost-effectiveness of
health care. METHODS: We calculated the difference between
the current incidence, prevalence, and mortality of major health
problems, and those in a situation without prevention and
medical care (“partial null”). Major health problems include
among others infectious diseases, cancers and cardiovascular dis-
eases. The partial null was reconstructed with (if relevant his-
torical) data on disease-speciﬁc mortality, case fatality, incidence,
and knowledge of the natural history, combined with trend
analysis, and with relevant literature on e.g. the impact of antibi-
otics on infectious disease epidemiology. The separate impact of
prevention (predominantly screening, vaccination) and medical
care was disentangled by isolating the impact of changes in
(stage-speciﬁc) incidence on the one hand, and changes in case
fatality and stage-speciﬁc prevalence on the other hand. Histor-
ical changes in health behaviour (predominantly smoking) as a
possible result of public health interventions was included in a
subanalysis. Other behavioural changes, such as weight gain and
sexual behaviour, were regarded autonomous trends. All epi-
demiological data were age- and sex-speciﬁc. With multistate
lifetable modeling techniques the incidence, prevalence of disease
stages, disease-speciﬁc disability weights, and mortality were
combined to calculate disability adjusted life expectancy in the
current and null situation. RESULTS: Preliminary results will be
presented on infectious diseases and cancers. CONCLUSIONS:
Conclusions cannot yet be drawn. In a next step the results will
be combined with recent cost-of-illness data to calculate disease-
speciﬁc cost-effectiveness of prevention and medical care.
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Although standardisation of costing methodology is a prerequi-
site for the consistency and comparability of health economic
results it is often seen as insufﬁcient. There exist a number of
country-speciﬁc guidelines for the costing process in economic
evaluations, but they often stay vague, especially with regard 
to the empirically based valuation of resource consumption.
OBJECTIVE: To present a system of unit costs for the health
care system in Germany that reﬂects a societal perspective and
that ensures consistency and comparability of study results
between different intervention studies by following uniform val-
uation standards. METHODS: The valuation set is compatible
with the measurement of resource consumption derived from
patient reported data. Data sources for the valuation are registry
data, national statistics, charges and tariffs. The primary goal
was to approximate a national average by considering and
weighting different reimbursement schemes of private and public
health insurance. RESULTS: The valuation set includes all basic
direct and indirect cost components. As an example the valua-
tions for physician services are based on average reimbursement
per visit: A visit to the general practitioner is valued €15, costs
for visits to specialists range from €14 (psychiatrist) to €80 (radi-
ologist). Inpatient stays are valued by department-speciﬁc per
diem rates ranging form €260 (orthopaedics) to €481(neuro
surgery). Cost of a work day lost amount to €89 following a
human capital approach. The friction period when adopting the
friction cost approach is 72 days. CONCLUSIONS: The pro-
posed set of unit costs is based on average valuation of resource
consumption. As most cost components are not derived from
market prices but are based on administrative cost and/or remu-
neration data, institutional changes may have impact on the val-
uation of resource consumption. This should be considered when
empirical unit costs are updated.
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OBJECTIVES: To compare and evaluate freeware options for
bootstrap analyses of incremental cost effectiveness data.
METHODS: Obenchain’s ICEplane software can be down-
loaded and installed from www.math.iupui.edu/~indyasa/
bobdown.htm. This software was compared against the web-
based bootstrap analyses available online at HealthStrategy.com.
Three datasets, that are downloadable from the ICEplane site,
were used in this software comparison. The three datasets are
from published studies dealing with abciximab (ABX), pindolol
(PIN) and tricyclic antidepressants (TCA). RESULTS: ICEplane
must be installed on MS Windows operating systems, in contrast
to the Health Strategy program that runs online through any
operating system with browsers including Internet Explorer,
Netscape or Firefox. Both software options provide output
